Skip to main content
TipRanks
Go Ultimate75% OFF

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Stock Price & Analysis

0 Followers

LOTUSEYE Stock Chart & Stats

₹103.70₹0.05(0.05%)
At close: 3:30 PM GMT+5:30
₹105₹110₹115Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
INR 100.70 - INR 104.05
52-Week Range
INR 97.60 - INR 153.00
Previous Close
INR 103.65
Volume
N/A
Average Volume (3M)
2,846
Market Cap
INR 2.16B
Enterprise Value
INR 2.69B
Total Cash (Recent Filing)
INR 38.27M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
439.7
Beta
0.54
Next Earnings
Feb 15, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Continued revenue expansion indicates that Lotus Eye Hospital is maintaining demand for its ophthalmology-focused consultations, diagnostics, procedures, and clinical services. Sustained top-line growth provides a foundation for future operating improvement if the company can convert additional volume into healthier margins.

Equity Support

The company retains a sizeable equity base relative to its reported debt, providing some balance-sheet support while it works to restore profitability. This capital cushion can improve resilience and preserve strategic flexibility, although the benefit is tempered by the recent increase in leverage.

Positive Operating Cash Flow

Positive operating cash flow shows that the core business is still generating cash from operations despite very low reported earnings. Although the amount has declined from prior peaks, this underlying cash contribution offers some internal funding capacity and supports ongoing clinical operations.

Bears Say

Severe Margin Deterioration

Sharp deterioration in both net and operating margins means revenue growth is currently producing little or no operating profit. Persistently weak profitability would reduce reinvestment capacity, make earnings more vulnerable to cost pressure, and limit the financial benefits of further volume growth.

Rapidly Rising Leverage

The rapid increase in debt relative to equity raises financial risk while earnings are under pressure. Higher leverage can increase fixed funding obligations and reduce flexibility to absorb continued margin weakness, particularly if the company needs additional capital to support expansion or operations.

Deeply Negative Free Cash Flow

Deeply negative free cash flow indicates that internally generated cash is not covering the company’s reinvestment and working-capital requirements. Combined with low net income and rising debt, this may create ongoing funding needs and reduce the quality and durability of cash generation.

LOTUSEYE FAQ

What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹97.60 and its highest was ₹153.00 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.16B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on Nov 11, 2026. The company reported ₹0.211 earnings per share for the quarter.
Is Lotus Eye Hospital And Institute Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays an annual dividend of ₹0.5 which represents an annual dividend yield of ―. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of ₹0.211 in its last earnings report. Following the earnings report the stock price went up 3.32%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology